Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nutrients|December 9, 2023
Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease-A Single Blinded Crossover TrialJack Feehan, Alexandra Mack, Caroline Tuck, et al.
Hepatology Communications|January 29, 2024
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitisSven M Francque, Alexander Hodge, Jerome Boursier, et al.
Frontiers in Pharmacology|November 9, 2017
The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver FibrosisMajid Alhomrani, Jeanne Correia, Marcus Zavou, et al.
Stem Cells Translational Medicine|April 15, 2024
Human Amniotic Epithelial Cell Transplantation is Safe and Well Tolerated in Patients with Compensated Cirrhosis: A First-in-Human TrialRebecca Lim, Alexander Hodge, Sherryne Warner, et al.
Hepatology (Baltimore, Md.)|July 16, 2008
Visceral fat: a key mediator of steatohepatitis in metabolic liver diseaseDavid van der Poorten, Kerry-Lee Milner, Jason Hui, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 12, 2023
Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantageDaniel Clayton-Chubb, William W Kemp, Ammar Majeed, et al.
Geroscience|November 28, 2024
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adultsDaniel Clayton-Chubb, Stuart K Roberts, Ammar Majeed, et al.
The New England Journal of Medicine|October 20, 2021
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASHSven M Francque, Pierre Bedossa, Vlad Ratziu, et al.
Pageof 2